Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients

NCT00221286 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

Chronic Hepatitis B
HIV Infections

Interventions

DRUG: pegylated interferon alfa-2a
DRUG: tenofovir DF / emtricitabine combination therapy
DRUG: pegIFN / TDF / FTC combination therapy

Sponsor

University Hospital, Bonn

Collaborators

[object Object]